cyclosporine and Carcinoma, Epidermoid

cyclosporine has been researched along with Carcinoma, Epidermoid in 76 studies

Research

Studies (76)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	21 (27.63)	18.2507
2000's	28 (36.84)	29.6817
2010's	25 (32.89)	24.3611
2020's	2 (2.63)	2.80

Authors

Authors	Studies
Enk, AH; Hadaschik, EN; Lonsdorf, AS; Menzer, C; Neuberger, A; Volk, N	1
Asano, K; Enokida, K; Hattori, S; Hayama, N; Hirabayashi, K; Horio, Y; Ito, Y; Miyaoka, M; Niimi, K; Oguma, T; Ohshinden, K; Takahashi, F; Takahashi, G; Takahashi, M; Takiguchi, H; Takihara, T; Tanaka, J	1
Cahoon, EK; Copeland, G; Engels, EA; Gonsalves, L; Kahn, AR; Laprise, C; Lynch, CF; Madeleine, MM; Pfeiffer, RM	1
Abikhair Burgo, M; Carucci, JA; Chen, J; Doudican, N; Felsen, D; Proby, C; Roudiani, N; Santana, AL	1
Gutzmer, R; Satzger, I; Schaper-Gerhardt, K; Schmitz-Rode, C; Walter, A	1
Dong, J; Dou, Z; Gao, L; Le, Z; Li, F; Li, S; Park, SY; Ren, W; Song, J; Wang, Q; Zhang, N; Zhi, K	1
Codarin, FR; Festa Neto, C; Oliveira, WRP; Silva, LLC; Souza, AAV; Tirico, MCCP	1
Iida, M; Ito, H; Kawano, T; Kumagai, Y; Odajima, H; Yamazaki, S	1
Cohen, DE; Miller, K; Stein, JA; Wu, TP	1
Djerbi, N; Dotto, GP; Dziunycz, PJ; Freiberger, SN; French, LE; Hofbauer, GFL; Iotzowa-Weiss, G; Lefort, K; Neu, J; Wu, X	1
Abramson, AK; Day, A; Menter, MA; Patel, M; Warren, RB	1
Weiss, JM	1
Biernat, W; Dębska-Ślizień, A; Imko-Walczuk, B; Kryś, A; Lizakowski, S; Rutkowski, B; Wojnarowska, F	1
Aljadir, DN; Boils, CL; Cantafio, AW	1
Abikhair, M; Bryan, T; Carucci, JA; Felsen, D; Gonzalez, J; Krueger, JG; Mitsui, H; Oberyszyn, TM; Ovits, C; Roudiani, N; Tober, KL; Yanofsky, V	1
Carucci, JA; Felsen, D; Santana, AL	1
Clemares, M; Jiménez, C; Manrique, A; Marqués, E; Moreno, E; Ortega, P; Vallejo, GH	1
Burleson, J; Dongari-Bagtzoglou, A; Dwivedi, P; Hull, D; Ioannidou, E; Shaqman, M	1
Claudy, A; Decullier, E; Euvrard, S; Faure, M; Kanitakis, J; Rival-Tringali, AL	1
Chen, YT; Cheng, LC; Chiang, CY; Chin, YT; Chiu, HC; Fu, E; Huang, SM; Tu, HP	1
Farid, SF; Zaki, AA	1
Adami, J; Bellocco, R; Fernberg, P; Höglund, P; Ingvar, A; Lindelöf, B; Smedby, KE; Tufveson, G	1
Bryne, M; Halstensen, TS; Husvik, C	1
Brooks, Y; Chang, S; Dotto, GP; Dziunycz, P; Hofbauer, GF; Lefort, K; Nguyen, BC; Wu, X	1
Di Lernia, V; Ricci, C	1
George, RE; Sugandhi, P	1
Hibino, M; Muro, Y; Shimoyama, Y; Sugiura, K; Tomita, Y	1
Athar, M; Elmets, CA; Grizzle, WE; Huang, CC; Kopelovich, L; Kurundkar, AR; Maheshwari, A; Timares, L; Walsh, SB; Xu, H; Xu, J	1
Athar, M; Elmets, CA; Kopelovich, L; Verney, ZM; Walsh, SB; Xu, J	1
Afaq, F; Arumugam, A; Athar, M; Elmets, CA; Walsh, SB; Xu, J	1
Brocard, A; Broeders, N; Campistol, JM; Chatelet, V; Dantal, J; Decullier, E; del Marmol, V; Dompmartin, A; Euvrard, S; Goffin, E; Hofbauer, GF; Kanitakis, J; Kessler, M; Morelon, E; Pouteil-Noble, C; Rostaing, L; Roux, AS; Serra, AL; Tromme, I	1
Kashyap, T; Rabinovitz, I	1
Bertoni, E; Caroti, L; Carta, P; Larti, A; Moscarelli, L; Paudice, N; Pimpinelli, N; Salvadori, M; Tsalouchos, A; Zanazzi, M	1
Agnew, KL; Bunker, CB	1
Balkay, L; Galuska, L; Goda, K; Juhász, I; Krasznai, Z; Márián, T; Mikecz, P; Nagy, H; Szabó, G; Szincsák, N; Trón, L	1
Centeno, J; Crovetto, M; Solano, D	1
Callan, MB; Mauldin, E; Preziosi, D	1
Gralla, J; Moosa, MR	1
Haustein, UF; Paasch, U	1
Kovach, R; Li, H; Rassekh, C; Tiu, J; van der Sloot, P; Zhang, P	1
Campanha, NH; Massucato, EM; Neppelenbroek, KH; Sanches, MH; Spolidorio, DM; Spolidorio, LC	1
Erbilen, E; Tunc, M	1
Allen, SD; Duncan, FJ; Ferketich, AK; Kusewitt, DF; Martin, J; Oberyszyn, TM; Thomas-Ahner, JM; Tober, KL; Vanbuskirk, AM; Wulff, BC	1
Abou Ayache, R; Bauwens, M; Belmouaz, M; Bridoux, F; Desport, E; Thierry, A; Touchard, G	1
Bette, M; Dünne, AA; Häussler, U; Heverhagen, JT; Mandic, R; Neubauer, A; Schulz, S; Weihe, E; Werner, JA	1
Chen, YT; Cheng, LC; Fu, E; Tu, HP; Wu, MH; Yang, SF	1
Kautzky, F; Köhler, LD; Vogt, HJ	1
Lozano, Y; Matthews, JP; Pak, AS; Petruzzelli, G; Raslan, WF; Taitz, A; Wright, MA; Young, MR	1
Davison, AM; Farmery, SM; Lodge, JP; London, NJ; Will, EJ	1
Claudy, A; Disant, F; Dureau, G; Euvrard, S; Finaz de Villaine, J; Kanitakis, J; Pouteil-Noble, C; Thivolet, J	1
de Dobbeleer, G; Noel, JC	1
Seddon, SV; Shepherd, JP; Thomas, DW	1
Green, C; Hawk, JL	1
Fabrizii, V; Swoboda, A	1
Cox, NH	1
Cunningham, J; Deeks, JJ; Glover, MT; Leigh, IM; Raftery, MJ	1
de Rooij, MJ; van de Kerkhof, PC	1
Cleary, I; Clynes, M; Davies, R; Graves, R; O'Beirne, G; Owen, P	1
Fischer, G; Küllertz, G; Lopez-Ilasaca, M; Schiene, C; Tradler, T; Wetzker, R	1
Bellotti, G; Bocchi, EA; Fiorelli, A; Higuchi, ML; Jatene, A; Pileggi, F; Stolf, N; Uip, D; Vieira, ML	1
Veness, MJ	1
Brennan, DC; Humphrey, PA; Jones, TR	1
Bossis, S; Charlin, JF; Colin, J; Le Callonnec, A; Macarez, R; Robinet, A	1
Ando, A; Aoe, M; Date, H; Nagahiro, I; Nagai, K; Okabe, K; Shimizu, N; Yamashita, M	1
Otley, CC; Pittelkow, MR	1
Atadja, P; Cohen, D; Roninson, IB; Uchiyama, N; Watanabe, T	1
Alaibac, M; Caforio, AL; Casarotto, D; Feltrin, G; Fortina, AB; Gambino, A; Peserico, A; Piaserico, S; Pompei, E; Testolin, L; Thiene, G; Tona, F; Volta, SD	1
Fauchald, P; Geiran, O; Gjersvik, P; Hansen, S; Leivestad, T; Møller, B; Pfeffer, P; Simonsen, S	1
Hail, N; Lotan, R	1
Gastman, BR; Johnson, DE; Rabinowich, H; Wang, GQ; Watkins, SC; Wieckowski, E; Yin, XM	1
Marcil, I; Stern, RS	1
Adams, GL; Matas, A; Preciado, DA	1
Chino, T; Kage, T; Mogi, M; Nakajima, J; Ueda, A; Yamada, T	1
Feutren, G	1
Blohmé, I; Larkö, O	1
Lustmann, J; Regev, E; Zeltser, R	1

Reviews

6 review(s) available for cyclosporine and Carcinoma, Epidermoid

Article	Year
The spectrum of oculocutaneous disease: Part II. Neoplastic and drug-related causes of oculocutaneous disease. Journal of the American Academy of Dermatology, 2014, Volume: 70, Issue:5 Topics: Aortic Coarctation; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Comorbidity; Cyclosporine; Dermatologic Agents; Eye Abnormalities; Eye Diseases; Eyelid Neoplasms; Humans; Lymphoma, T-Cell, Cutaneous; Melanoma; Mohs Surgery; Multiple Myeloma; Neurocutaneous Syndromes; Retinoids; Sebaceous Gland Neoplasms; Skin Diseases; Skin Neoplasms; Stevens-Johnson Syndrome; Syndrome; Tumor Necrosis Factor-alpha	2014
Interleukin-22 and Cyclosporine in Aggressive Cutaneous Squamous Cell Carcinoma. Dermatologic clinics, 2017, Volume: 35, Issue:1 Topics: Carcinoma, Squamous Cell; Cell Proliferation; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Interleukin-22; Interleukins; Skin Neoplasms; Transplant Recipients; Tumor Microenvironment	2017
Skin cancer in liver transplant recipients. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2000, Volume: 6, Issue:3 Topics: Animals; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Keratosis; Liver Transplantation; Postoperative Complications; Skin Neoplasms; Tacrolimus	2000
Squamous cell carcinoma of the head and neck in solid organ transplant recipients. Head & neck, 2002, Volume: 24, Issue:4 Topics: Anti-Inflammatory Agents; Azathioprine; Carcinoma, Squamous Cell; Cyclosporine; Head and Neck Neoplasms; Humans; Immunosuppressive Agents; Incidence; Middle Aged; Minnesota; Organ Transplantation; Prednisone; Survival Analysis	2002
The optimal use of cyclosporin A in autoimmune diseases. Journal of autoimmunity, 1992, Volume: 5 Suppl A Topics: Autoimmune Diseases; Blood Pressure; Carcinoma, Squamous Cell; Cyclosporine; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Kidney; Lymphoma	1992
Lip carcinoma in renal allograft recipient with long-term immunosuppressive therapy. Oral surgery, oral medicine, and oral pathology, 1992, Volume: 73, Issue:4 Topics: Adult; Atenolol; Azathioprine; Carcinoma, Squamous Cell; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Lip Neoplasms; Prednisone	1992

Trials

3 trial(s) available for cyclosporine and Carcinoma, Epidermoid

Article	Year
Sirolimus and secondary skin-cancer prevention in kidney transplantation. The New England journal of medicine, 2012, Jul-26, Volume: 367, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Calcineurin Inhibitors; Carcinoma, Squamous Cell; Cyclosporine; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Sirolimus; Skin Neoplasms; Tacrolimus	2012
Treatment with ozone/oxygen-pneumoperitoneum results in complete remission of rabbit squamous cell carcinomas. International journal of cancer, 2008, May-15, Volume: 122, Issue:10 Topics: Animals; Anti-Inflammatory Agents; Body Weight; Carcinoma, Squamous Cell; Cyclosporine; Dexamethasone; Head and Neck Neoplasms; Immunosuppressive Agents; Lung Neoplasms; Oxygen; Ozone; Pneumoperitoneum; Rabbits; Remission Induction; Survival Rate	2008
No difference in skin cancer incidence with or without cyclosporine--a 5-year perspective. Transplantation proceedings, 1992, Volume: 24, Issue:1 Topics: Azathioprine; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Follow-Up Studies; Humans; Incidence; Keratoacanthoma; Kidney Transplantation; Prednisolone; Skin Neoplasms	1992

Other Studies

67 other study(ies) available for cyclosporine and Carcinoma, Epidermoid

Article	Year
Expression of p53 up-regulated modulator of apoptosis (PUMA) in non-melanoma skin cancer of long-term immunosuppressed solid organ transplant recipients compared to immunocompetent patients. European journal of dermatology : EJD, 2021, Oct-01, Volume: 31, Issue:5 Topics: Aged; Aged, 80 and over; Apoptosis Regulatory Proteins; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Female; Gene Expression Regulation, Neoplastic; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Organ Transplantation; Proto-Oncogene Proteins; Risk Factors; Skin Neoplasms; Ultraviolet Rays; Up-Regulation	2021
Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined with Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis. Internal medicine (Tokyo, Japan), 2021, Feb-15, Volume: 60, Issue:4 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Squamous Cell; Cyclosporine; Humans; Idiopathic Pulmonary Fibrosis; Lung; Lung Neoplasms; Male; Pyridones; Treatment Outcome	2021
Risk of lip cancer after solid organ transplantation in the United States. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2019, Volume: 19, Issue:1 Topics: Adolescent; Adult; Aged; Azathioprine; Carcinoma, Squamous Cell; Child; Child, Preschool; Cyclosporine; DNA Damage; Ethnicity; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Infant; Infant, Newborn; Lip Neoplasms; Male; Middle Aged; Organ Transplantation; Postoperative Complications; Risk Factors; Transplant Recipients; United States; Young Adult	2019
Ruxolitinib inhibits cyclosporine-induced proliferation of cutaneous squamous cell carcinoma. JCI insight, 2018, 09-06, Volume: 3, Issue:17 Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cyclosporine; Disease Models, Animal; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Interleukin-22; Interleukins; Janus Kinase 1; Mice; Mice, Nude; Nitriles; Organ Transplantation; Pyrazoles; Pyrimidines; Receptors, Interleukin; Signal Transduction; Skin Neoplasms; STAT1 Transcription Factor; STAT3 Transcription Factor	2018
The mTOR-inhibitor Sirolimus decreases the cyclosporine-induced expression of the oncogene ATF3 in human keratinocytes. Journal of dermatological science, 2018, Volume: 92, Issue:2 Topics: Activating Transcription Factor 3; Calcineurin Inhibitors; Carcinogenesis; Carcinoma, Squamous Cell; Cell Culture Techniques; Cell Line, Tumor; Cyclosporine; Down-Regulation; Humans; Immunosuppressive Agents; Keratinocytes; Oncogenes; Organ Transplantation; Sirolimus; Skin; Skin Neoplasms; TOR Serine-Threonine Kinases; Ultraviolet Rays	2018
Cyclosporine A Suppresses the Malignant Progression of Oral Squamous Cell Carcinoma in vitro. Anti-cancer agents in medicinal chemistry, 2019, Volume: 19, Issue:2 Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Movement; Cell Proliferation; Cell Survival; Cyclosporine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Mouth Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured; Wound Healing	2019
Skin lesions in organ transplant recipients: a study of 177 consecutive Brazilian patients. International journal of dermatology, 2019, Volume: 58, Issue:4 Topics: Adolescent; Adult; Aged; Azathioprine; Brazil; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Child; Cyclosporine; Dermatomycoses; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Keratosis, Actinic; Male; Middle Aged; Organ Transplantation; Risk Factors; Skin Diseases, Infectious; Skin Neoplasms; Tacrolimus; Warts; Young Adult	2019
Patient with esophageal cancer showing remission of nephrotic syndrome after esophagectomy: report of a case. Surgery today, 2013, Volume: 43, Issue:12 Topics: Aged; Carcinoma, Squamous Cell; Cyclosporine; Drug Therapy, Combination; Esophageal Neoplasms; Esophagectomy; Humans; Laparotomy; Lymph Node Excision; Male; Nephrotic Syndrome; Prednisolone; Thoracotomy; Treatment Outcome	2013
Keratoacanthomas arising in association with prurigo nodules in pruritic, actinically damaged skin. Journal of the American Academy of Dermatology, 2013, Volume: 69, Issue:3 Topics: Acitretin; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryotherapy; Cyclosporine; Dermatologic Agents; Eczema; Female; Humans; Keratoacanthoma; Keratolytic Agents; Keratosis, Actinic; Prurigo; Pruritus; Retrospective Studies	2013
The oncogene ATF3 is potentiated by cyclosporine A and ultraviolet light A. The Journal of investigative dermatology, 2014, Volume: 134, Issue:7 Topics: Activating Transcription Factor 3; Carcinoma, Squamous Cell; Cyclosporine; Humans; Immunosuppressive Agents; Keratinocytes; Neoplasms, Radiation-Induced; NF-E2-Related Factor 2; Organ Culture Techniques; Organ Transplantation; Primary Cell Culture; Reactive Oxygen Species; Skin; Skin Neoplasms; Tumor Cells, Cultured; Ultraviolet Rays	2014
[Journal-Club]. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2014, Volume: 12, Issue:9 Topics: Activating Transcription Factor 3; Animals; Carcinoma, Squamous Cell; Cyclosporine; Female; Human papillomavirus 16; Human papillomavirus 18; Human papillomavirus 6; Humans; Intercellular Signaling Peptides and Proteins; Interleukin-23; Keratinocytes; Male; Neoplasms, Radiation-Induced; Nociceptors; Papillomavirus E7 Proteins; Papillomavirus Infections; Psoriasis; Sensory Receptor Cells; Skin; Skin Neoplasms; Ultraviolet Rays	2014
Sebaceous carcinoma in patients receiving long-term immunosuppresive treatment: case report and literature review. Transplantation proceedings, 2014, Volume: 46, Issue:8 Topics: Aged, 80 and over; Azathioprine; Carcinoma, Squamous Cell; Cyclosporine; Fatal Outcome; Female; Humans; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Neoplasms, Multiple Primary; Sebaceous Gland Neoplasms; Skin Neoplasms	2014
Use of the PD-1 Pathway Inhibitor Nivolumab in a Renal Transplant Patient With Malignancy. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2016, Volume: 16, Issue:8 Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Lung Neoplasms; Male; Nivolumab; Prednisone; Programmed Cell Death 1 Receptor	2016
Cyclosporine A immunosuppression drives catastrophic squamous cell carcinoma through IL-22. JCI insight, 2016, 06-02, Volume: 1, Issue:8 Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclosporine; Humans; Immunosuppressive Agents; Interleukin-22; Interleukins; Mice; Receptors, Interleukin; Skin Neoplasms	2016
Development of lymphoproliferative disease after liver transplantation. Transplantation proceedings, 2008, Volume: 40, Issue:9 Topics: Adult; Carcinoma, Squamous Cell; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Liver Transplantation; Lymphoproliferative Disorders; Male; Retrospective Studies; Risk Factors; Skin Neoplasms; Survival Analysis; Survivors; Tacrolimus	2008
Oral Candida infection and colonization in solid organ transplant recipients. Oral microbiology and immunology, 2009, Volume: 24, Issue:3 Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis, Oral; Carcinoma, Squamous Cell; Case-Control Studies; Chromogenic Compounds; Colony Count, Microbial; Cyclosporine; Diabetes Complications; Female; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mouth; Mouth Mucosa; Mycological Typing Techniques; Prednisone; Saliva; Smoking; Smoking Cessation; Tongue	2009
Conversion from calcineurin inhibitors to sirolimus reduces vascularization and thickness of post-transplant cutaneous squamous cell carcinomas. Anticancer research, 2009, Volume: 29, Issue:6 Topics: Adult; Aged; Angiogenesis Inhibitors; Calcineurin Inhibitors; Carcinoma, Squamous Cell; Cohort Studies; Cyclosporine; Female; Graft Rejection; Heart Transplantation; Humans; Immunoenzyme Techniques; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Neovascularization, Pathologic; Postoperative Complications; Sirolimus; Skin Neoplasms; Treatment Outcome	2009
Cyclosporine A enhances apoptosis in gingival keratinocytes of rats and in OECM1 cells via the mitochondrial pathway. Journal of periodontal research, 2009, Volume: 44, Issue:6 Topics: Animals; Apoptosis; Apoptosis Inducing Factor; bcl-2-Associated X Protein; Carcinoma, Squamous Cell; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cyclosporine; DNA Fragmentation; fas Receptor; Flow Cytometry; Fluorescent Dyes; Gingiva; Humans; Immunosuppressive Agents; Indoles; Keratinocytes; Male; Mitochondria; Oligonucleotide Array Sequence Analysis; Proto-Oncogene Proteins c-bcl-2; Random Allocation; Rats; Rats, Sprague-Dawley	2009
Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up. Cornea, 2009, Volume: 28, Issue:9 Topics: Aged; Carcinoma in Situ; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Conjunctival Neoplasms; Corneal Diseases; Cyclosporine; Drug Therapy, Combination; Eye Neoplasms; Female; Follow-Up Studies; Humans; Male; Mitomycin; Neoplasm Invasiveness; Ophthalmologic Surgical Procedures; Treatment Outcome	2009
Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:8 Topics: Adolescent; Adult; Aged; Azathioprine; Carcinoma, Squamous Cell; Case-Control Studies; Child; Cohort Studies; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Lung Transplantation; Male; Middle Aged; Risk Factors; Skin Neoplasms; Sweden; Time Factors; Young Adult	2010
c-Jun N-terminal kinase negatively regulates epidermal growth factor-induced cyclooxygenase-2 expression in oral squamous cell carcinoma cell lines. European journal of oral sciences, 2009, Volume: 117, Issue:6 Topics: Anthracenes; Calcineurin Inhibitors; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclooxygenase 2; Cyclosporine; Dactinomycin; Enzyme Inhibitors; Epidermal Growth Factor; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mouth Neoplasms; NFATC Transcription Factors; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Synthesis Inhibitors; Transcription, Genetic	2009
Opposing roles for calcineurin and ATF3 in squamous skin cancer. Nature, 2010, May-20, Volume: 465, Issue:7296 Topics: Activating Transcription Factor 3; Animals; Calcineurin; Calcineurin Inhibitors; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Cellular Senescence; Cyclosporine; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Keratinocytes; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; NFATC Transcription Factors; Signal Transduction; Skin Neoplasms; Tumor Suppressor Protein p53	2010
Cutaneous malignancies during treatment with efalizumab and infliximab: When temporal relationship does not mean causality. The Journal of dermatological treatment, 2011, Volume: 22, Issue:4 Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Carcinoma, Squamous Cell; Cyclosporine; Dermatologic Agents; Female; Humans; Infliximab; Psoriasis; PUVA Therapy; Skin Neoplasms; Time Factors; Tumor Necrosis Factor-alpha	2011
Use of combination therapy of topical mitomycin C and cyclosporine a as an adjunct to surgery for corneal and conjunctival intraepithelial neoplasia and invasive squamous cell carcinoma. Cornea, 2011, Volume: 30, Issue:4 Topics: Administration, Topical; Carcinoma in Situ; Carcinoma, Squamous Cell; Combined Modality Therapy; Conjunctival Neoplasms; Corneal Diseases; Cyclosporine; Drug Therapy, Combination; Humans; Mitomycin; Ophthalmologic Surgical Procedures	2011
Cyclosporin A induces the unfolded protein response in keratinocytes. Archives of dermatological research, 2011, Volume: 303, Issue:7 Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclophilins; Cyclosporine; Endoplasmic Reticulum Chaperone BiP; Heat-Shock Proteins; Humans; Keratinocytes; Psoriasis; RNA, Small Interfering; Transcription Factor CHOP; Transforming Growth Factor beta1; Unfolded Protein Response	2011
Cyclosporine a mediates pathogenesis of aggressive cutaneous squamous cell carcinoma by augmenting epithelial-mesenchymal transition: role of TGFβ signaling pathway. Molecular carcinogenesis, 2011, Volume: 50, Issue:7 Topics: Animals; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Division; Cell Line, Tumor; Cyclosporine; Epithelial-Mesenchymal Transition; Female; Fluorescent Antibody Technique; Humans; In Situ Nick-End Labeling; Mice; Mice, Nude; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Skin Neoplasms; Transforming Growth Factor beta; Transplantation, Heterologous	2011
Procarcinogenic effects of cyclosporine A are mediated through the activation of TAK1/TAB1 signaling pathway. Biochemical and biophysical research communications, 2011, May-13, Volume: 408, Issue:3 Topics: Adaptor Proteins, Signal Transducing; Animals; Carcinogens; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cyclosporine; Enzyme Activation; Female; Humans; Immunosuppressive Agents; MAP Kinase Kinase Kinases; Mice; Mice, Nude; Xenograft Model Antitumor Assays	2011
Combined inhibition of p38 and Akt signaling pathways abrogates cyclosporine A-mediated pathogenesis of aggressive skin SCCs. Biochemical and biophysical research communications, 2012, Aug-24, Volume: 425, Issue:2 Topics: Animals; Carcinoma, Squamous Cell; Cyclosporine; Female; Humans; Immunosuppressive Agents; MAP Kinase Signaling System; Mice; Mice, Nude; Molecular Targeted Therapy; Organ Transplantation; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Skin Neoplasms	2012
The calcium/calcineurin pathway promotes hemidesmosome stability through inhibition of β4 integrin phosphorylation. The Journal of biological chemistry, 2012, Sep-21, Volume: 287, Issue:39 Topics: Animals; Calcineurin; Calcium; Carcinoma, Squamous Cell; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Cyclosporine; Enzyme Activation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Hemidesmosomes; Humans; Integrin beta4; Neoplasm Proteins; Phosphorylation; Protein Kinase C	2012
Conversion from calcineurin inhibitors to everolimus with low-dose cyclosporine in renal transplant recipients with squamous cell carcinoma of the skin. Transplantation proceedings, 2012, Volume: 44, Issue:7 Topics: Calcineurin Inhibitors; Carcinoma, Squamous Cell; Cyclosporine; Dose-Response Relationship, Drug; Everolimus; Humans; Kidney Transplantation; Sirolimus; Skin Neoplasms	2012
Multiple cutaneous squamous carcinoma in a psoriatic associated with ciclosporin, alcohol abuse and ultraviolet radiation exposure which were suppressed by acitretin. Journal of the European Academy of Dermatology and Venereology : JEADV, 2003, Volume: 17, Issue:1 Topics: Acitretin; Alcoholism; Carcinoma, Squamous Cell; Cyclosporine; Humans; Immunosuppressive Agents; Keratolytic Agents; Leg; Male; Middle Aged; Psoriasis; PUVA Therapy; Skin Neoplasms; Ultraviolet Rays	2003
In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance. European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:8 Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorodeoxyglucose F18; Humans; Metabolic Clearance Rate; Mice; Mice, SCID; Radioisotope Dilution Technique; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tissue Distribution; Tomography, Emission-Computed; Verapamil	2003
[Recurrent polychondritis: apropos of a case]. Acta otorrinolaringologica espanola, 2003, Volume: 54, Issue:10 Topics: Aspirin; Autoimmune Diseases; Azathioprine; Biopsy; Carcinoma, Squamous Cell; Conjunctivitis; Cyclosporine; Diagnosis, Differential; Disease Progression; Drug Therapy, Combination; Facial Neoplasms; Female; Fever; Hearing Disorders; Humans; Immunosuppressive Agents; Middle Aged; Nasal Obstruction; Otitis Media with Effusion; Polychondritis, Relapsing; Prednisone; Scleritis	2003
Multiple papillomavirus-associated epidermal hamartomas and squamous cell carcinomas in situ in a dog following chronic treatment with prednisone and cyclosporine. Veterinary dermatology, 2005, Volume: 16, Issue:5 Topics: Anemia; Animals; Carcinoma, Squamous Cell; Cyclosporine; Diagnosis, Differential; Dog Diseases; Dogs; Drug Administration Schedule; Drug Therapy, Combination; Female; Hamartoma; Immunocompromised Host; Papillomavirus Infections; Prednisone; Skin Neoplasms	2005
Skin cancer in renal allograft recipients--experience in different ethnic groups residing in the same geographical region. Clinical transplantation, 2005, Volume: 19, Issue:6 Topics: Adult; Azathioprine; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Skin Neoplasms; South Africa; Sunlight; White People	2005
Aggressive undifferentiated squamous cell carcinoma in an immunosuppressed patient after kidney transplantation. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2005, Volume: 3, Issue:1 Topics: Acitretin; Adjuvants, Immunologic; Administration, Oral; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Counseling; Cyclosporine; Follow-Up Studies; Humans; Imiquimod; Immunocompromised Host; Immunosuppressive Agents; Keratolytic Agents; Keratosis; Kidney Transplantation; Male; Middle Aged; Ointments; Skin; Skin Neoplasms; Sunscreening Agents; Time Factors	2005
Molecular basis of posttransplant squamous cell carcinoma: the potential role of cyclosporine a in carcinogenesis. The Laryngoscope, 2006, Volume: 116, Issue:5 Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Transformation, Neoplastic; Cyclosporine; Female; Gene Expression Regulation, Neoplastic; Humans; Immunosuppressive Agents; Male; Molecular Biology; Mouth Neoplasms; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Tissue Transplantation; Transplantation Immunology	2006
Oral health in renal transplant recipients administered cyclosporin A or tacrolimus. Oral diseases, 2006, Volume: 12, Issue:3 Topics: Adult; Calcium Channel Blockers; Candida; Carcinoma, Squamous Cell; Cyclosporine; Drug Therapy, Combination; Female; Gingival Overgrowth; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mouth Neoplasms; Saliva; Stomatitis, Herpetic; Tacrolimus	2006
Topical cyclosporine-a combined with mitomycin C for conjunctival and corneal squamous cell carcinoma. American journal of ophthalmology, 2006, Volume: 142, Issue:4 Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Corneal Diseases; Cyclosporine; Drug Therapy, Combination; Eye Neoplasms; Humans; Immunosuppressive Agents; Male; Middle Aged; Mitomycin	2006
Clinically relevant immunosuppressants influence UVB-induced tumor size through effects on inflammation and angiogenesis. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2007, Volume: 7, Issue:12 Topics: Animals; Blood Vessels; Carcinoma, Squamous Cell; Cyclosporine; Disease Models, Animal; Drug Therapy, Combination; Female; Immunosuppressive Agents; Inflammation; Mice; Mice, Hairless; Mycophenolic Acid; Neoplasms, Radiation-Induced; Neovascularization, Pathologic; Sirolimus; Skin Neoplasms; Tacrolimus; Ultraviolet Rays	2007
Long-term maintenance of calcineurin inhibitor monotherapy reduces the risk for squamous cell carcinomas after kidney transplantation compared with bi- or tritherapy. Transplantation proceedings, 2007, Volume: 39, Issue:8 Topics: Adult; Calcineurin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Drug Therapy, Combination; Graft Survival; Humans; Immunosuppressive Agents; Immunotherapy; Kidney Transplantation; Middle Aged; Retrospective Studies	2007
Expression of p21 and p53 in rat gingival and human oral epithelial cells after cyclosporine A treatment. Journal of periodontal research, 2008, Volume: 43, Issue:1 Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Cyclosporine; Epithelial Cells; Genes, p53; Gingiva; Humans; Immunosuppressive Agents; Jaw, Edentulous, Partially; Rats; RNA, Messenger; Tumor Suppressor Protein p53	2008
[Multiple cutaneous neoplasms in cyclosporine therapy after kidney transplantation]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1995, Volume: 46, Issue:9 Topics: Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Cyclosporine; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Administration Schedule; Dysplastic Nevus Syndrome; Follow-Up Studies; Humans; Immune Tolerance; Kidney Transplantation; Male; Melanoma; Middle Aged; Neoplasms, Multiple Primary; Precancerous Conditions; Skin Neoplasms	1995
Immune parameters of mice bearing human head and neck cancer. Cancer immunology, immunotherapy : CII, 1995, Volume: 40, Issue:5 Topics: Animals; Antibodies, Neoplasm; Carcinoma, Squamous Cell; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Concanavalin A; Culture Media, Conditioned; Cyclosporine; Female; Graft Survival; Immunocompromised Host; Interleukin-2; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Pharyngeal Neoplasms; Splenomegaly; Transplantation, Heterologous	1995
Risk of neoplasia in renal transplant patients. Lancet (London, England), 1995, Aug-12, Volume: 346, Issue:8972 Topics: Adult; Carcinoma, Squamous Cell; Cyclosporine; Data Collection; Databases, Factual; England; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Neoplasms; Retrospective Studies; Risk Factors; Skin Neoplasms; Survival Analysis	1995
Aggressive squamous cell carcinomas in organ transplant recipients. Transplantation proceedings, 1995, Volume: 27, Issue:2 Topics: Azathioprine; Carcinoma, Squamous Cell; Cyclosporine; Heart Transplantation; Humans; Immunosuppression Therapy; Kidney Transplantation; Neoplasm Metastasis; Neoplasm Recurrence, Local; Retinoids; Retrospective Studies; Risk Factors; Skin Neoplasms	1995
Development of human papillomavirus-associated Buschke-Löwenstein penile carcinoma during cyclosporine therapy for generalized pustular psoriasis. Journal of the American Academy of Dermatology, 1994, Volume: 31, Issue:2 Pt 1 Topics: Carcinoma, Squamous Cell; Carcinoma, Verrucous; Cyclosporine; Humans; Male; Papillomaviridae; Papillomavirus Infections; Penile Neoplasms; Psoriasis; Tumor Virus Infections	1994
Systemic immunosuppression and oral malignancy: a report of a case and review of the literature. The British journal of oral & maxillofacial surgery, 1993, Volume: 31, Issue:6 Topics: Adult; Carcinoma, Squamous Cell; Cyclosporine; Humans; Immunocompromised Host; Immunologic Surveillance; Immunosuppression Therapy; Kidney Transplantation; Lip Neoplasms; Male; Prednisolone; Skin Neoplasms	1993
Cutaneous malignancy related to cyclosporin A therapy. Clinical and experimental dermatology, 1993, Volume: 18, Issue:1 Topics: Adult; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Humans; Male; Methotrexate; Psoriasis; Skin Neoplasms	1993
Tonsillar carcinoma in a renal graft recipient treated with cyclosporine A. Clinical nephrology, 1993, Volume: 39, Issue:5 Topics: Adult; Carcinoma, Squamous Cell; Cyclosporine; Drug Therapy, Combination; Humans; Kidney Transplantation; Male; Prednisolone; Risk Factors; Time Factors; Tonsillar Neoplasms	1993
Squamous cell carcinoma arising in lichen planus of the penis during topical cyclosporin therapy. Clinical and experimental dermatology, 1996, Volume: 21, Issue:4 Topics: Carcinoma, Squamous Cell; Cyclosporine; Humans; Immunosuppressive Agents; Lichen Planus; Male; Middle Aged; Penile Neoplasms	1996
Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients. Lancet (London, England), 1997, Feb-08, Volume: 349, Issue:9049 Topics: Azathioprine; Carcinoma, Squamous Cell; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Prednisolone; Skin Neoplasms	1997
Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclosporin treatment: response to long-term acitretin maintenance. The British journal of dermatology, 1997, Volume: 136, Issue:2 Topics: Acitretin; Carcinoma, Squamous Cell; Cyclosporine; Humans; Immunosuppressive Agents; Keratolytic Agents; Male; Middle Aged; Neoplasms, Multiple Primary; Psoriasis; PUVA Therapy; Skin Neoplasms	1997
An homogeneous assay for measuring the uptake and efflux of radiolabelled drugs in adherent cells. Journal of biochemical and biophysical methods, 1997, Jun-09, Volume: 34, Issue:3 Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carbon Radioisotopes; Carcinoma, Squamous Cell; Cell Adhesion; Cell Division; Cell Survival; Cyclosporine; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Humans; Thymidine; Verapamil	1997
Effects of FK506-binding protein 12 and FK506 on autophosphorylation of epidermal growth factor receptor. The Journal of biological chemistry, 1998, Apr-17, Volume: 273, Issue:16 Topics: Adenosine Triphosphate; Carcinoma, Squamous Cell; Carrier Proteins; Cell Membrane; Cyclosporine; DNA-Binding Proteins; ErbB Receptors; Genetic Variation; Heat-Shock Proteins; Humans; Kinetics; Peptidylprolyl Isomerase; Phosphorylation; Point Mutation; Recombinant Proteins; Tacrolimus; Tacrolimus Binding Proteins; Tumor Cells, Cultured	1998
Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1998, Volume: 17, Issue:4 Topics: Adult; Carcinoma, Squamous Cell; Chagas Cardiomyopathy; Chemoprevention; Chronic Disease; Cocarcinogenesis; Cyclosporine; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Lung Diseases; Lymphoproliferative Disorders; Male; Mutagens; Neoplasms; Neurilemmoma; Nitroimidazoles; Recurrence; Sarcoma, Kaposi; Skin Neoplasms; Survival Rate; Trypanocidal Agents	1998
Cardiac transplant-related cutaneous malignancies in an Australian recipient: immunosuppression, friend or foe? Clinical oncology (Royal College of Radiologists (Great Britain)), 1998, Volume: 10, Issue:3 Topics: Adult; Australia; Azathioprine; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Glucocorticoids; Head and Neck Neoplasms; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Myocardial Ischemia; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Opportunistic Infections; Prednisolone; Skin Neoplasms	1998
Transplantation of vascularized allogeneic skeletal muscle for scalp reconstruction in renal transplant patient. Transplantation proceedings, 1998, Volume: 30, Issue:6 Topics: Carcinoma, Squamous Cell; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Muscle, Skeletal; Scalp; Skin Neoplasms; Skin Transplantation; Transplantation, Autologous; Transplantation, Homologous	1998
Conjunctival epithelial neoplasias in organ transplant patients receiving cyclosporine therapy. Cornea, 1999, Volume: 18, Issue:4 Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Cryosurgery; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Ophthalmologic Surgical Procedures	1999
[Two cases of thymic carcinoma effectively treated by preoperative chemotherapy]. Kyobu geka. The Japanese journal of thoracic surgery, 2000, Volume: 53, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclosporine; Doxorubicin; Female; Humans; Male; Middle Aged; Preoperative Care; Thymus Neoplasms; Treatment Outcome; Vincristine	2000
Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein. International journal of oncology, 2000, Volume: 17, Issue:3 Topics: Adenosine Triphosphatases; Amino Acid Substitution; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Calcium Channel Blockers; Carcinoma, Squamous Cell; Colchicine; Cyclosporine; Cyclosporins; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Neoplasm Proteins; Paclitaxel; Point Mutation; Structure-Activity Relationship; Transfection; Tumor Cells, Cultured; Verapamil; Vinblastine	2000
Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy. Circulation, 2000, Nov-07, Volume: 102, Issue:19 Suppl 3 Topics: Age Distribution; Azathioprine; Carcinoma, Squamous Cell; Comorbidity; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Keratosis; Male; Middle Aged; Prednisone; Proportional Hazards Models; Risk Factors; Skin Neoplasms; Skin Pigmentation; Sunlight	2000
Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients? Transplant international : official journal of the European Society for Organ Transplantation, 2000, Volume: 13 Suppl 1 Topics: Azathioprine; Carcinoma, Squamous Cell; Cyclosporine; Drug Therapy, Combination; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Postoperative Complications; Prednisolone; Proportional Hazards Models; Retrospective Studies; Risk; Skin Neoplasms	2000
Mitochondrial permeability transition is a central coordinating event in N-(4-hydroxyphenyl)retinamide-induced apoptosis. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2000, Volume: 9, Issue:12 Topics: Anticarcinogenic Agents; Apoptosis; Ascorbic Acid; Carcinoma, Squamous Cell; Cell Division; Cyclosporine; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Fenretinide; Fluoresceins; Fluorescent Dyes; Humans; Intracellular Membranes; Membrane Potentials; Mitochondria; Oxidation-Reduction; Permeability; Reactive Oxygen Species; Rhodamine 123; Skin Neoplasms; Tumor Cells, Cultured	2000
Tumor-induced apoptosis of T cells: amplification by a mitochondrial cascade. Cancer research, 2000, Dec-15, Volume: 60, Issue:24 Topics: Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Blotting, Western; Bongkrekic Acid; Carbocyanines; Carcinoma, Squamous Cell; Carrier Proteins; Caspase 9; Caspases; Coculture Techniques; Cyclosporine; Cytochrome c Group; Cytosol; DNA; Enzyme Activation; Enzyme Inhibitors; Etoposide; fas Receptor; Fluorescent Antibody Technique; Fluorescent Dyes; Head and Neck Neoplasms; Humans; Jurkat Cells; Lymphocytes; Microscopy, Fluorescence; Mitochondria; Oligopeptides; Protein Transport; Subcellular Fractions; T-Lymphocytes; Tumor Cells, Cultured	2000
Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study. Lancet (London, England), 2001, Sep-29, Volume: 358, Issue:9287 Topics: Carcinoma, Squamous Cell; Cross-Over Studies; Cyclosporine; Female; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Prospective Studies; Psoriasis; PUVA Therapy; Risk Factors; Skin Neoplasms	2001
Enhancement by cyclosporin A of metastasis from hamster cheek pouch carcinoma. Archives of oral biology, 1992, Volume: 37, Issue:7 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinoma, Squamous Cell; Cocarcinogenesis; Cricetinae; Cyclosporine; Lung Neoplasms; Lymphatic Metastasis; Male; Mesocricetus; Mouth Neoplasms; Neck; Neoplasm Invasiveness; Neoplasm Staging; Time Factors	1992